"Hope and Progress:
The Latest Developments in
Pancreatic Cancer Research"


On September 29, 2022, PanCAN brought together a panel of research and treatment experts for an in-depth discussion on the latest in pancreatic cancer research.

Topics included:

  • The latest scientific advances in precision medicine, immunotherapy, drug development, early detection and screening for high-risk individuals.
  • How PanCAN’s Precision Promise clinical trial platform and the PanCAN Early Detection Initiative are revolutionizing pancreatic cancer detection and treatment.
  • The importance of PanCAN’s comprehensive approach to investing in research, which ensures that the pancreatic cancer field is collaborative and keeps the patient at the center.
  • PanCAN’s record-breaking research investment of almost $25 million, bringing PanCAN’s total research investment to $174 million to date, all thanks to generous donors.


card image

Julie M. Fleshman, JD, MBA

PanCAN President and CEO, leading the way for more than two decades in PanCAN’s approach to take bold steps to make progress in pancreatic cancer research and improve patient outcomes

card image

Lynn Matrisian, PhD, MBA

PanCAN Chief Science Officer, leading our research and clinical initiatives, including the PanCAN Early Detection Initiative, PanCAN's Research Grants Program and more

card image

Andrew Lowy, MD

Surgical Oncologist and Chief of the Division of Surgical Oncology at UC San Diego Health, past chair and current member of PanCAN's Scientific & Medical Advisory Board

card image

Anirban Maitra, MBBS

Professor of Pathology and Translational Molecular Pathology and Scientific Director of the Sheikh Ahmed Pancreatic Cancer Research Center at The University of Texas MD Anderson Cancer Center, Houston, past chair and current member of PanCAN's Scientific & Medical Advisory Board

card image

Jonathan Pachter, PhD

VerastemTM Oncology Chief Scientific Officer

card image

Nicolette Rodriguez, MD, MPH

Instructor of Medicine at Harvard Medical School and Co-Director of Fellowship Initiatives for Trainees Underrepresented in Medicine in the Department of Medicine at Brigham and Women’s Hospital

Support Our Research

You make progress possible. Donate today to support groundbreaking research

Contact PanCAN Patient Services team

for answers to any questions you have about pancreatic cancer, treatment options and more. Our expert case managers are here from 7 a.m. to 5 p.m. PT, Monday through Friday, to help. Contact us at 877-573-9971 or via our contact form.